Amanda Louise Murphy - Mar 25, 2022 Form 4 Insider Report for MAXCYTE, INC. (MXCT)

Role
Chief Financial Officer
Signature
/s/ Brian F. Leaf, attorney-in-fact
Stock symbol
MXCT
Transactions as of
Mar 25, 2022
Transactions value $
$0
Form type
4
Date filed
3/29/2022, 04:16 PM
Previous filing
Nov 16, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MXCT Employee Stock Option (right to buy) Award $0 +142K $0.00 142K Mar 25, 2022 Common Stock 142K $7.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying this option vest on March 25, 2023 and the remaining 75% vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service with the Issuer at each vesting date.